Is IL-17 required to control tuberculosis?

  • Andrea M. Cooper
Part of the Progress in Inflammation Research book series (PIR)


We review the state of knowledge regarding the role of IL-17 in tuberculosis (TB). IL-17 is clearly induced following exposure to mycobacteria in mice and humans and therefore its role in both protection and the immunopathological consequences of infection must be fully defined. IL-17-producing T cells can be seen in both mice and humans and these cytokine-producing cells are dependent to a large degree upon IL-23. Based on what we know of the function of IL-17 and the nature of TB, it would be surprising if this were a disease where IL-17 would have a dramatic impact; indeed the experimental data suggests that it is not required for control of bacterial growth. However, while it is clear that IL-17 is present during TB, its function(s) is not yet known. Key questions that will help elucidate function include - the role the mycobacteria plays in induction and regulation of the IL-17 response and the role IL-17 plays in modulating the inflammatory response during chronic disease.


Mycobacterium Tuberculosis Chronic Granulomatous Disease Mycobacterial Infection Bacterial Burden Granulomatous Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Flynn J, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19: 93–129PubMedCrossRefGoogle Scholar
  2. 2.
    North R, Jung Y (2004) Immunity to tuberculosis. Annu Rev Immunol 22: 599–623PubMedCrossRefGoogle Scholar
  3. 3.
    Scott-Browne J, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot J, Rudensky A, Bevan M, Urdahl K (2007) Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 204: 2159–2169PubMedCrossRefGoogle Scholar
  4. 4.
    Khader S, Pearl J, Sakamoto K, Gilmartin L, Bell G, Jelley-Gibbs D, Ghilardi N, deSauvage F, Cooper A (2005) IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigenspecific IFN-gamma responses if IL-12p70 is available. J Immunol 175: 788–795PubMedGoogle Scholar
  5. 5.
    Scriba T, Kalsdorf B, Abrahams D-A, Isaacs F, Hofmeister J, Black G, Hassan H, Wilkinson R, Walzl G, Gelderbloem S et al (2008) Distinct, specific IL-17 and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 180: 1962–1970PubMedGoogle Scholar
  6. 6.
    Umemura M, Yahagi A, Hamada S, Begum M, Watanabe H, Kawakami K, Suda T, Sudo K, Nakae S, Iwakura Y et al (2007) IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis Bacille Calmette-Guerin infection. J Immunol 178: 3786–3796PubMedGoogle Scholar
  7. 7.
    Lockhart E, Green A, Flynn J (2006) IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177: 4662–4669PubMedGoogle Scholar
  8. 8.
    D’Souza CD, Cooper AM, Frank AA, Mazzaccaro RJ, Bloom BR, Orme IM (1997) An anti-inflammatory role for γ δ T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol 158: 1217–1221PubMedGoogle Scholar
  9. 9.
    Romani L, Fallarino F, De Luca A, Montagnoli C, D’Angelo C, Zelante T, Vacca C, Bistoni F, Fioretti M, Grohmann U et al (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211–215PubMedCrossRefGoogle Scholar
  10. 10.
    Cooper AM, Segal BH, Frank AA, Holland SM, Orme IM (2000) Transient loss of resistance to pulmonary tuberculosis in p47phox-/-mice. Infect Immun 68: 1231–1234PubMedCrossRefGoogle Scholar
  11. 11.
    Michel M, Keller A, Paget C, Fujio M, Trottein F, Savage P, Wong C, Schneider E, Dy M, Leite-de-Moraes M (2007) Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 204: 995–1001PubMedCrossRefGoogle Scholar
  12. 12.
    Weaver C, Hatton R, Mangan P, Harrington L (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25: 821–852PubMedCrossRefGoogle Scholar
  13. 13.
    Stockinger B, Veldhoen M, Martin B (2007) Th17 T cells: Linking innate and adaptive immunity. Semin Immunol 19: 353–361PubMedCrossRefGoogle Scholar
  14. 14.
    Khader S, Bell G, Pearl J, Fountain J, Rangel-Moreno J, Cilley G, Shen F, Eaton S, Gaffen S, Swain S et al (2007) IL-23 and IL-17 in establishment of protective pulmonary CD4+ T cell responses upon vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369–377PubMedCrossRefGoogle Scholar
  15. 15.
    Cruz A, Khader S, Torrado E, Fraga A, Pearl J, Pedrosa J, Cooper A, Castro A (2006) CE:IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 177: 1416–1420PubMedGoogle Scholar
  16. 16.
    Stockinger B, Veldhoen M (2007) Differentiation and function of Th17 T cells. Curr Opin Immunol 19: 281–286PubMedCrossRefGoogle Scholar
  17. 17.
    Ivanov I, Zhou L, Littman D (2007) Transcriptional regulation of Th17 cell differentiation. Semin Immunol 19: 409–417PubMedCrossRefGoogle Scholar
  18. 18.
    McGeachy M, Cua D (2007) The link between IL-23 and Th17 cell-mediated immune pathologies. Semin Immunol 19: 372–376PubMedCrossRefGoogle Scholar
  19. 19.
    Kano S, Sato K, Morishita Y, Vollstedt S, Kim S, Bishop K, Honda K, Kubo M, Taniguchi T (2008) The contribution of transcription factor IRF1 to the interferon-gammainterleukin 12 signaling axis and T(H)1 versus T(H)-17 differentiation of CD4(+) T cells. Nat Immunol 9: 34–41PubMedCrossRefGoogle Scholar
  20. 20.
    Acosta-Rodriguez E, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8: 639–646PubMedCrossRefGoogle Scholar
  21. 21.
    Stark M, Huo Y, Burcin T, Morris M, Olson T, Ley K (2005) Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22: 285–294PubMedCrossRefGoogle Scholar
  22. 22.
    Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J et al (2001) Requirement of Interleukin-17 receptor signalling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194: 519–527PubMedCrossRefGoogle Scholar
  23. 23.
    Kolls J, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21: 467–476PubMedCrossRefGoogle Scholar
  24. 24.
    Hsu H, Yang P, Wang J, Wu Q, Myers R, Chen J, Yi J, Guentert T, Tousson A, Stanus A et al (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9: 166–175PubMedCrossRefGoogle Scholar
  25. 25.
    Mangan P, Harrington L, O’Quinn D, Helms W, Bullard D, Elson C, Hatton R, Wahl S, Schoeb T, Weaver C (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231–234PubMedCrossRefGoogle Scholar
  26. 26.
    Huang W, Na L, Fidel P, Schwarzenberger P (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190: 624–631PubMedCrossRefGoogle Scholar
  27. 27.
    Wu Q, Martin R, Rino J, Breed R, Torres R, Chu H (2007) IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 9: 78–86PubMedCrossRefGoogle Scholar
  28. 28.
    Chackerian A, Chen S, Brodie S, Mattson J, McClanahan T, Kastelein R, Bowman E (2006) Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection. Infect Immun 74: 6092–6099PubMedCrossRefGoogle Scholar
  29. 29.
    Happel K, Lockhart E, Mason C, Porretta E, Keoshkerian E, Odden A, Nelson S, Ramsay A (2005) Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect Immun 73: 5782–5788PubMedCrossRefGoogle Scholar
  30. 30.
    Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, Jouanguy E, Boisson-Dupuis S, Fieschi C, Picard C et al (2006) Inborn errors of IL-12/23-and IFN-gamma-mediated immunity: Molecular, cellular, and clinical features. Semin Immunol 18: 347–361PubMedCrossRefGoogle Scholar
  31. 31.
    Hoeve M, de Boer T, Langenberg D, Sanal O, Verreck F, Ottenhoff T (2003) IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency. Eur J Immunol 33: 3393–3397PubMedCrossRefGoogle Scholar
  32. 32.
    Hoeve M, Savage N, de Boer T, Langenberg D, de Waal Malefyt R, Ottenhoff T, Verreck F (2006) Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 36: 661–670PubMedCrossRefGoogle Scholar
  33. 33.
    Cargill M, Schrodi S, Chang M, Garcia V, Brandon R, Callis K, Matsunami N, Ardlie K, Civello D, Catanese J et al (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80: 273–290PubMedCrossRefGoogle Scholar
  34. 34.
    Duerr R, Taylor K, Brant S, Rioux J, Silverberg M, Daly M, Steinhart A, Abraham C, Regueiro M, Griffiths A et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461–1463PubMedCrossRefGoogle Scholar
  35. 35.
    Wozniak T, Ryan A, Triccas J, Britton W (2006) Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infect Immun 74: 557–565PubMedCrossRefGoogle Scholar
  36. 36.
    Wozniak T, Ryan A, Britton W (2006) Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J Immunol 177: 8684–8692PubMedGoogle Scholar
  37. 37.
    Stumhofer J, Laurence A, Wilson E, Huang E, Tato C, Johnson L, Villarino A, Huang Q, Yoshimura A, Sehy D et al (2006) Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7: 937–945PubMedCrossRefGoogle Scholar
  38. 38.
    Batten M, Li J, Yi S, Kljavin N, Danilenko D, Lucas S, Lee J, de Sauvage F, Ghilardi N (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7: 929–936PubMedCrossRefGoogle Scholar
  39. 39.
    Rhoades ER, Frank AA, Orme IM (1997) Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis 78: 57–66PubMedCrossRefGoogle Scholar
  40. 40.
    Aujla S, Dubin P, Kolls J (2007) Th17 cells and mucosal host defense. Semin Immunol 19: 377–382PubMedCrossRefGoogle Scholar
  41. 41.
    Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, Belladonna M, Vacca C, Conte C, Mosci P et al (2007) The IL-23and the IL-17 pathway promotes inflammation and impairs antifungal immune resistance. Eur J Immunol 37: 2695–2706PubMedCrossRefGoogle Scholar
  42. 42.
    Seiler P, Aichele P, Bandermann S, Hauser A, Lu B, Gerard N, Gerard C, Ehlers S, Mollenkopf H, Kaufmann S (2003) Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur J Immunol 33: 2676–2686PubMedCrossRefGoogle Scholar
  43. 43.
    Keller C, Hoffmann R, Lang R, Brandau S, Hermann C, Ehlers S (2006) Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect Immun 74: 4295–4309PubMedCrossRefGoogle Scholar
  44. 44.
    Ulrichs T, Kosmiadi G, Trusov V, Jörg S, Pradl L, Titukhina M, Mishenko V, Gushina N, Kaufmann S (2004) Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J Pathol 204: 217–228PubMedCrossRefGoogle Scholar
  45. 45.
    Tsai M, Chakravarty S, Zhu G, Xu J, Tanaka K, Koch C, Tufariello J, Flynn J, Chan J (2006) Characterization of the tuberculous granuloma in murine and human lungs: Cellular composition and relative tissue oxygen tension. Cell Microbiol 8: 218–232PubMedCrossRefGoogle Scholar
  46. 46.
    Kahnert A, Höpken U, Stein M, Bandermann S, Lipp M, Kaufmann S (2007) Mycobac terium tuberculosis triggers formation of lymphoid structure in murine lungs. J Infect Dis 195: 46–54PubMedCrossRefGoogle Scholar
  47. 47.
    Bosio C, Gardner D, Elkins K (2000) Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: Delay in dissemination and development of lung pathology. J Immunol 164: 6417–6425PubMedGoogle Scholar
  48. 48.
    Maglione P, Xu J, Chan J (2007) B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J Immunol 178: 7222–7234PubMedGoogle Scholar
  49. 49.
    Aggarwal S, Ghilardi N, Xie M, de Sauvage FJ, Gurney AL (2002) Interleukin-23 promotes a distinct CD4+ T cell activation state characterised by the production of IL-17. J Biol Chem 278: 1910–1914PubMedCrossRefGoogle Scholar
  50. 50.
    Leibundgut-Landmann S, Groß O, Robinson M, Osorio F, Slack E, Tsoni S, Schweighoffer E, Tybulewicz V, Brown G, Ruland J et al (2007) Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8: 630–638PubMedCrossRefGoogle Scholar
  51. 51.
    Yadav M, Schorey J (2006) The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 108: 3168–3175PubMedCrossRefGoogle Scholar
  52. 52.
    Rothfuchs A, Bafica A, Feng C, Egen J, Williams D, Brown G, Sher A (2007) Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J Immunol 179: 3463–3471PubMedGoogle Scholar
  53. 53.
    Hohl T, Van Epps H, Rivera A, Morgan L, Chen P, Feldmesser M, Pamer E (2005) Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog 1: e30CrossRefGoogle Scholar
  54. 54.
    Steele C, Rapaka R, Metz A, Pop S, Williams D, Gordon S, Kolls J, Brown G (2005) The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog 1: e42CrossRefGoogle Scholar
  55. 55.
    Rao V, Fujiwara N, Porcelli S, Glickman M (2005) Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 201: 535–543PubMedCrossRefGoogle Scholar
  56. 56.
    Kursar M, Koch M, Mittrücker H, Nouailles G, Bonhagen K, Kamradt T, Kaufmann S (2007) Cutting edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 178: 2661–2665PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2009

Authors and Affiliations

  • Andrea M. Cooper
    • 1
  1. 1.Trudeau Institute, Inc.Saranac LakeUSA

Personalised recommendations